265 related articles for article (PubMed ID: 31031763)
1. Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations.
Ruiz-García R; Martínez-Hernández E; García-Ormaechea M; Español-Rego M; Sabater L; Querol L; Illa I; Dalmau J; Graus F
Front Immunol; 2019; 10():769. PubMed ID: 31031763
[TBL] [Abstract][Full Text] [Related]
2. Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies.
Arnaldos-Pérez C; Vilaseca A; Naranjo L; Sabater L; Dalmau J; Ruiz-García R; Graus F
Front Immunol; 2023; 14():1173484. PubMed ID: 37207233
[TBL] [Abstract][Full Text] [Related]
3. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
[TBL] [Abstract][Full Text] [Related]
4. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes.
Tschernatsch M; Gross O; Kneifel N; Kaps M; Blaes F
Autoimmun Rev; 2009 Jun; 8(7):549-51. PubMed ID: 19393214
[TBL] [Abstract][Full Text] [Related]
5. SOX1 antibody-related paraneoplastic neurological syndromes: clinical correlates and assessment of laboratory diagnostic techniques.
Vabanesi M; Pinto AL; Vogrig A; Goncalves D; Rogemond V; Joubert B; Fabien N; Honnorat J; Muñiz-Castrillo S
J Neurol; 2023 Mar; 270(3):1691-1701. PubMed ID: 36512064
[TBL] [Abstract][Full Text] [Related]
6. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
Titulaer MJ; Klooster R; Potman M; Sabater L; Graus F; Hegeman IM; Thijssen PE; Wirtz PW; Twijnstra A; Smitt PA; van der Maarel SM; Verschuuren JJ
J Clin Oncol; 2009 Sep; 27(26):4260-7. PubMed ID: 19667272
[TBL] [Abstract][Full Text] [Related]
7. Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy.
Tschernatsch M; Singh P; Gross O; Gerriets T; Kneifel N; Probst C; Malas S; Kaps M; Blaes F
J Neuroimmunol; 2010 Sep; 226(1-2):177-80. PubMed ID: 20701982
[TBL] [Abstract][Full Text] [Related]
8. Anti-SOX1 antibody-positive paraneoplastic neurological syndrome presenting with Lambert-Eaton myasthenic syndrome and small cell lung cancer: A case report.
Li C; Wang X; Sun L; Deng H; Han Y; Zheng W
Thorac Cancer; 2020 Feb; 11(2):465-469. PubMed ID: 31880403
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes.
Déchelotte B; Muñiz-Castrillo S; Joubert B; Vogrig A; Picard G; Rogemond V; Pinto AL; Lombard C; Desestret V; Fabien N; Honnorat J
Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32170044
[TBL] [Abstract][Full Text] [Related]
10. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
11. [Paraneoplastic neurologic syndromes: laboratory diagnostics and immunological aspects].
Hayden Z; Böröcz K; Csizmadia Z; Kellermayer Z; Balogh P; Berki T
Magy Onkol; 2019 Sep; 63(3):261-267. PubMed ID: 31533147
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic autoimmunity and small-cell lung cancer: Neurological and serological accompaniments.
Zekeridou A; Majed M; Heliopoulos I; Lennon VA
Thorac Cancer; 2019 Apr; 10(4):1001-1004. PubMed ID: 30810271
[TBL] [Abstract][Full Text] [Related]
13. Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer.
Sabater L; Höftberger R; Boronat A; Saiz A; Dalmau J; Graus F
PLoS One; 2013; 8(3):e60438. PubMed ID: 23536908
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of different immunological methods for the detection of antineuronal antibodies in paraneoplastic neurological syndromes.
Tampoia M; Zucano A; Antico A; Giometto B; Bonaguri C; Alessio MG; Radice A; Platzgummer S; Bizzaro N
Immunol Invest; 2010 Jan; 39(2):186-95. PubMed ID: 20136624
[TBL] [Abstract][Full Text] [Related]
15. Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome.
Michalak S; Cofta S; Piatek A; Rybacka J; Wysocka E; Kozubski W
Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):156-61. PubMed ID: 20156748
[TBL] [Abstract][Full Text] [Related]
16. The Diagnostic Value of Onconeural Antibodies Depends on How They Are Tested.
Ruiz-García R; Martínez-Hernández E; Saiz A; Dalmau J; Graus F
Front Immunol; 2020; 11():1482. PubMed ID: 32760403
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of anti-SOX1 reactivity in various neurological disorders.
Berger B; Dersch R; Ruthardt E; Rasiah C; Rauer S; Stich O
J Neurol Sci; 2016 Oct; 369():342-346. PubMed ID: 27653921
[TBL] [Abstract][Full Text] [Related]
18. Imbalances in circulating lymphocyte subsets in Hu antibody associated paraneoplastic neurological syndromes.
de Beukelaar JW; Sillevis Smitt PA; Hop WC; Kraan J; Hooijkaas H; Verjans GM; Gratama JW
Eur J Neurol; 2007 Dec; 14(12):1383-91. PubMed ID: 18028190
[TBL] [Abstract][Full Text] [Related]
19. Microtubule-associated protein 1B: Novel paraneoplastic biomarker.
Gadoth A; Kryzer TJ; Fryer J; McKeon A; Lennon VA; Pittock SJ
Ann Neurol; 2017 Feb; 81(2):266-277. PubMed ID: 28074593
[TBL] [Abstract][Full Text] [Related]
20. The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders.
Maddison P; Titulaer MJ; Verschuuren JJ; Gozzard P; Lang B; Irani SR; Sabater L; Graus F; Murray A; Chapman CJ
J Neuroimmunol; 2019 Jan; 326():14-18. PubMed ID: 30445363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
